Jared Gollob, Chief Medical Officer at Kymera Therapeutics, Inc. (KYMR), sold 30,000 shares at $60.17 ($1.8M) on 2021-03-15, disclosed to the SEC on 2021-03-15.
Open-market sale of $1.8M KYMR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.05 | 4,695 | $282K | 15.6% |
| 2 | $60.05 | 4,695 | $282K | 15.6% |
| 3 | $60.17 | 10,305 | $620K | 34.4% |
| 4 | $60.17 | 10,305 | $620K | 34.4% |
| Total | $60.13 avg | 30,000 | $1.8M | 100% |
| Filing → |
| KYMR | SELL | 2025-10-15 | $7.3M | — | Filing → |
| KYMR | SELL | 2025-10-14 | $187K | — | Filing → |
| KYMR | SELL | 2025-03-03 | $317K | — | Filing → |